{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:52:20Z","timestamp":1793472740935,"version":"4.5.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Extracorporeal photopheresis (ECP) is an immunomodulatory therapy characterized by the exposure of leukocytes to 8-methoxypsoralen and UV light irradiation, followed by reinfusion of the treated cells into the patient. ECP is considered a safe and well-tolerated procedure that preserves the beneficial aspects of immunity, such as antitumor and antiviral activities, with a low rate of side effects. Currently, ECP is used for the treatment of immune-mediated conditions, such as cutaneous T-cell lymphoma, graft-versus-host disease, solid organ transplant rejection, and autoimmune disorders. ECP is an immunomodulatory therapy characterized by multiple complex events that lead to the modulation of the immune response. Modifying the activity of myeloid antigen-presenting cells with apoptotic cell remnants is key to the therapeutic action of ECP; however, because the pathological roles of macrophages and dendritic cells are context specific, the precise effects of ECP vary between different diseases. Consequently, we need a much better understanding of the immunology and pharmacology of ECP to extend its use in solid organ transplantation and beyond. During the past decades, important advances were made using animal models of ECP, leading to a better mechanistic understanding and its more rational use in many T cell\u2013mediated conditions. This review summarizes the available information on animal models of ECP, providing insights into the mechanisms of action, therapeutic applications, limitations, and translational potential from preclinical animal models to human clinical practice.<\/jats:p>","DOI":"10.1097\/txd.0000000000001824","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T21:00:52Z","timestamp":1756846852000},"page":"e1824","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Extracorporeal Photopheresis: From Animal Models to Clinical Practice"],"prefix":"10.1097","volume":"11","author":[{"given":"In\u00eas","family":"Morgado","sequence":"first","affiliation":[{"name":"Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany."},{"name":"Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaki Manoja","family":"Vinnakota","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6565-3393","authenticated-orcid":false,"given":"Robert","family":"Zeiser","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany."},{"name":"German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany."},{"name":"Comprehensive Cancer Center Freiburg (CCCF), University of Freiburg, Freiburg, Germany."},{"name":"Centre for Biological Signaling Studies (BIOSS) and Centre for Integrative Biological Signaling Studies (CIBSS), Freiburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"R1-20260423","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fmed.2018.00236","article-title":"Extracorporeal photopheresis\u2014an overview.","volume":"5","author":"Cho","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R2-20260423","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ajh.21166","article-title":"Extracorporeal photopheresis: lighting the way to immunomodulation.","volume":"83","author":"Babic","year":"2008","journal-title":"Am J Hematol"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1525-1594.1994.tb03340.x","article-title":"Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection.","volume":"18","author":"Wolfe","year":"1994","journal-title":"Artif Organs"},{"key":"R4-20260423","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1056\/NEJMc1912274","article-title":"Extracorporeal photopheresis for colitis induced by checkpoint-inhibitor therapy.","volume":"382","author":"Apostolova","year":"2020","journal-title":"N Engl J Med"},{"key":"R5-20260423","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/ajts.AJTS_87_16","article-title":"Extracorporeal photopheresis: review of technical aspects.","volume":"11","author":"Arora","year":"2017","journal-title":"Asian J Transfus Sci"},{"key":"R6-20260423","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1011-1344(96)07432-5","article-title":"Clinical and mechanistic aspects of photopheresis.","volume":"39","author":"van Iperen","year":"1997","journal-title":"J Photochem Photobiol B"},{"key":"R7-20260423","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1111\/jdv.16890","article-title":"European dermatology forum\u2014updated guidelines on the use of extracorporeal photopheresis 2020\u2014part 1.","volume":"34","author":"Knobler","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R8-20260423","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1039\/c2pp25144b","article-title":"Photopheresis (extracorporeal photochemotherapy).","volume":"12","author":"Trautinger","year":"2013","journal-title":"Photochem Photobiol Sci"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/14712598.2012.688025","article-title":"Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art.","volume":"12","author":"Martino","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"R10-20260423","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000508479","article-title":"Extracorporeal photopheresis: a case of immunotherapy ahead of its time.","volume":"47","author":"Vieyra-Garcia","year":"2020","journal-title":"Transfus Med Hemother"},{"key":"R11-20260423","doi-asserted-by":"crossref","first-page":"1086006","DOI":"10.3389\/fimmu.2023.1086006","article-title":"Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers.","volume":"14","author":"Bojanic","year":"2023","journal-title":"Front Immunol"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fimmu.2015.00349","article-title":"Extracorporeal photopheresis: tolerogenic or immunogenic cell death? beyond current dogma.","volume":"6","author":"Hannani","year":"2015","journal-title":"Front Immunol"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/s41375-022-01701-2","article-title":"Extracorporeal photopheresis in acute and chronic steroid\u2011refractory graft-versus-host disease: an evolving treatment landscape.","volume":"36","author":"Greinix","year":"2022","journal-title":"Leukemia"},{"key":"R14-20260423","first-page":"232","article-title":"Extracorporeal photopheresis: scientific and technical considerations for improving clinical management of patients.","volume":"4","author":"Garban","year":"2014","journal-title":"J Stem Cell Res Ther"},{"key":"R15-20260423","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.","volume":"316","author":"Edelson","year":"1987","journal-title":"N Engl J Med"},{"key":"R16-20260423","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jca.21217","article-title":"Extracorporeal photopheresis: clinical use so far.","volume":"27","author":"Sanford","year":"2012","journal-title":"J Clin Apher"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/cancers16010141","article-title":"Mogamulizumab combined with extracorporeal photopheresis as a novel therapy in erythrodermic cutaneous T-cell lymphoma.","volume":"16","author":"Ninosu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R18-20260423","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0959-8049(21)00708-5","article-title":"Prec-P-01-Preclinical investigation of new targeted combination therapies in cutaneous T-cell lymphoma.","volume":"156","author":"\u015eener","year":"2021","journal-title":"Eur J Cancer"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000508169","article-title":"Extracorporeal photopheresis in graft-versus-host disease.","volume":"47","author":"Drexler","year":"2020","journal-title":"Transfus Med Hemother"},{"key":"R20-20260423","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol"},{"key":"R21-20260423","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets.","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"R22-20260423","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fimmu.2020.00081","article-title":"Extracorporeal photopheresis (ECP) and the potential of novel biomarkers in optimizing management of acute and chronic graft vs. host disease (GvHD).","volume":"11","author":"Mankarious","year":"2020","journal-title":"Front Immunol"},{"key":"R23-20260423","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood-2002-01-0068","article-title":"Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease.","volume":"100","author":"Gorgun","year":"2002","journal-title":"Blood"},{"key":"R24-20260423","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1097\/HS9.0000000000000581","article-title":"Immunomodulatory therapies for the treatment of graft-versus-host disease.","volume":"5","author":"Braun","year":"2021","journal-title":"Hemasphere"},{"key":"R25-20260423","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41409-020-01122-8","article-title":"Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.","volume":"56","author":"Maas-Bauer","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"R26-20260423","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.cdd.4401699","article-title":"Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion.","volume":"13","author":"Kleinclauss","year":"2006","journal-title":"Cell Death Differ"},{"key":"R27-20260423","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2007-11-125542","article-title":"Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells.","volume":"112","author":"Gatza","year":"2008","journal-title":"Blood"},{"key":"R28-20260423","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.bbmt.2010.12.712","article-title":"Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination.","volume":"17","author":"Capitini","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R29-20260423","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1182\/blood-2014-02-555128","article-title":"Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models.","volume":"124","author":"Florek","year":"2014","journal-title":"Blood"},{"key":"R30-20260423","doi-asserted-by":"crossref","first-page":"e105896","DOI":"10.1371\/journal.pone.0105896","article-title":"Modified extracorporeal photopheresis with cells from a healthy donor for acute graft-versus-host disease in a mouse model.","volume":"9","author":"Budde","year":"2014","journal-title":"PLoS One"},{"key":"R31-20260423","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/vox.12723","article-title":"An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice.","volume":"113","author":"Budde","year":"2018","journal-title":"Vox Sang"},{"key":"R32-20260423","doi-asserted-by":"crossref","first-page":"1371554","DOI":"10.3389\/fimmu.2024.1371554","article-title":"The value of extracorporeal photopheresis as an immunosuppression-modifying approach in solid organ transplantation: a potential solution to an unmet medical need.","volume":"15","author":"Augusto","year":"2024","journal-title":"Front Immunol"},{"key":"R33-20260423","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.ajt.2024.03.012","article-title":"The use of extracorporeal photopheresis in solid organ transplantation-current status and future directions.","volume":"24","author":"Barten","year":"2024","journal-title":"Am J Transplant"},{"key":"R34-20260423","doi-asserted-by":"crossref","first-page":"e1831","DOI":"10.1097\/TXD.0000000000001831","article-title":"Extracorporeal photopheresis in lung transplantation: present applications and emerging research.","volume":"11","author":"Alemanno","year":"2025","journal-title":"Transplant Direct"},{"key":"R35-20260423","doi-asserted-by":"crossref","first-page":"e14333","DOI":"10.1111\/ctr.14333","article-title":"Extracorporeal photopheresis and its role in heart transplant rejection: prophylaxis and treatment.","volume":"35","author":"Slomovich","year":"2021","journal-title":"Clin Transplant"},{"key":"R36-20260423","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.transci.2015.02.004","article-title":"Extracorporeal photopheresis in heart transplant rejection.","volume":"52","author":"Patel","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"R37-20260423","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/TP.0000000000002168","article-title":"Extracorporeal photopheresis for bronchiolitis obliterans syndrome after lung transplantation.","volume":"102","author":"Hachem","year":"2018","journal-title":"Transplantation"},{"key":"R38-20260423","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.healun.2008.02.015","article-title":"Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis [published correction appears in J Heart Lung Transplant. 2008 Oct;27(10):1190. Guo, Wing Hong [corrected to Guo, Lingling]].","volume":"27","author":"George","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R39-20260423","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bbrc.2010.04.062","article-title":"Uptake of donor lymphocytes treated with 8-methoxypsoralen and ultraviolet A light by recipient dendritic cells induces CD4+CD25+Foxp3+ regulatory T cells and down-regulates cardiac allograft rejection.","volume":"395","author":"Zheng","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"R40-20260423","article-title":"Lung transplant recipients on long-term extracorporeal photopheresis.","author":"Isenring","journal-title":"Clin Transplant"},{"key":"R41-20260423","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/01902140902718205","article-title":"Extracorporeal photopheresis in a rat model of pulmonary fibrosis.","volume":"35","author":"Remund","year":"2009","journal-title":"Exp Lung Res"},{"key":"R42-20260423","doi-asserted-by":"crossref","first-page":"e159229","DOI":"10.1172\/JCI159229","article-title":"Reprogramming alveolar macrophage responses to TGF-\u03b2 reveals CCR2+ monocyte activity that promotes bronchiolitis obliterans syndrome.","volume":"132","author":"Liu","year":"2022","journal-title":"J Clin Invest"},{"key":"R43-20260423","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/TP.0000000000004536","article-title":"Extracorporeal photopheresis suppresses transplant fibrosis by inducing decorin expression in alveolar macrophages.","volume":"107","author":"Hutchinson","year":"2023","journal-title":"Transplantation"},{"key":"R44-20260423","doi-asserted-by":"crossref","first-page":"e1809","DOI":"10.1097\/TXD.0000000000001809","article-title":"Exploring the role of extracorporeal photopheresis in kidney transplant management.","volume":"11","author":"Nicoli","year":"2025","journal-title":"Transplant Direct"},{"key":"R45-20260423","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.transci.2018.02.019","article-title":"Reflections on the usefulness of extracorporeal photopheresis in renal transplant rejection: a concise review of the involved mechanisms and therapeutic perspectives [published correction appears in Transfus Apher Sci. 2018 Oct;57(5):689. doi: 10.1016\/j.transci.2018.08.002].","volume":"57","author":"Del Fante","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"R46-20260423","doi-asserted-by":"crossref","first-page":"10840","DOI":"10.3389\/ti.2023.10840","article-title":"Extracorporeal photopheresis improves graft survival in a full-mismatch rat model of kidney transplantation.","volume":"36","author":"Pi\u00f1eiro","year":"2023","journal-title":"Transpl Int"},{"key":"R47-20260423","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0022-202X(89)90180-2","article-title":"Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.","volume":"92","author":"Perez","year":"1989","journal-title":"J Invest Dermatol"},{"key":"R48-20260423","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1016\/j.transproceed.2018.04.066","article-title":"Infusion of lymphocytes treated with 8-methoxypsoralen and ultraviolet a light induces CD19+IL-10+ regulatory B cells and promotes skin allograft survival.","volume":"50","author":"Wei","year":"2018","journal-title":"Transplant Proc"},{"key":"R49-20260423","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jca.21367","article-title":"Extracorporeal photopheresis as a therapy for autoimmune diseases.","volume":"30","author":"Kuzmina","year":"2015","journal-title":"J Clin Apher"},{"key":"R50-20260423","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.transci.2015.02.005","article-title":"Extracorporeal photopheresis for the treatment of autoimmune diseases.","volume":"52","author":"Adamski","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"R51-20260423","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12967-019-2066-1","article-title":"Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept.","volume":"17","author":"Coppard","year":"2019","journal-title":"J Transl Med"},{"key":"R52-20260423","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12967-024-05105-x","article-title":"Extracorporeal photopheresis reduces inflammation and joint damage in a rheumatoid arthritis murine model.","volume":"22","author":"Lin","year":"2024","journal-title":"J Transl Med"},{"key":"R53-20260423","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clim.2010.01.018","article-title":"Experimental extracorporeal photopheresis therapy significantly delays the development of diabetes in non-obese diabetic mice.","volume":"135","author":"Xia","year":"2010","journal-title":"Clin Immunol"},{"key":"R54-20260423","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.4049\/jimmunol.174.10.5968","article-title":"Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells.","volume":"174","author":"Maeda","year":"2005","journal-title":"J Immunol"},{"key":"R55-20260423","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.4049\/jimmunol.181.9.5956","article-title":"Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells.","volume":"181","author":"Maeda","year":"2008","journal-title":"J Immunol"},{"key":"R56-20260423","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s004150170169","article-title":"Extracorporeal photochemotherapy reduces the incidence of relapses in experimental allergic encephalomyelitis in DA rats.","volume":"248","author":"Cavaletti","year":"2001","journal-title":"J Neurol"},{"key":"R57-20260423","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1034\/j.1600-0781.2002.02o754.x","article-title":"Photopheresis affects the course of experimental allergic encephalomyelitis in Lewis rat.","volume":"18","author":"Chabannes","year":"2002","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"R58-20260423","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1158\/0008-5472.CAN-18-0171","article-title":"Extracorporeal photochemotherapy drives monocyte-to-dendritic cell maturation to induce anticancer immunity.","volume":"78","author":"Ventura","year":"2018","journal-title":"Cancer Res"},{"key":"R59-20260423","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ccell.2025.01.004","article-title":"Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity.","volume":"43","author":"Braun","year":"2025","journal-title":"Cancer Cell"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TXD.0000000000001824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:31:56Z","timestamp":1786037516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TXD.0000000000001824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001824","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}